Collaborations Pharmaceuticals, Inc.

No Disease Is Too Small

[Danny Miller - MEPAN Foundation @mepancure]

So much gratitude for @eperlste, @OphirKlein, Tomas Wald, @jessplao and #UCSF team that have made this project possible. This was the first dedicated project to help find a cure for MEPAN. Regardless of outcome, we have advanced the science. Onward.

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

Collaborations Pharmaceuticals, Inc. Awarded A Phase II SBIR award from NIEHS/NIH to Develop MegaTox® software https://t.co/a9uKTOQ6sj via @ein_news

[Pitt Hopkins Research Foundation @PittHopkins]

It’s a beautiful morning in Philly! Our riders are going strong at the 2022 Million Dollar Bike Ride! Thank you to everyone who is riding, donated, and fundraised helping us get to over $60,000 for Pitt Hopkins research!! #mdbr2022 #pitthopkins

[EIN Presswire: Press Releases @EINPresswirePR]

On International Batten Awareness Day Collaborations Pharmaceuticals, Inc․ was awarded a Phase II SBIR from NINDS for developing an enzyme replacement therapy for CLN1 https://t.co/9xyIxwucOA

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

Join Dr. @collabchem PhD, DSc, TODAY as he presents "Applying #MachineLearning to Build a Company Pipeline" at Cambridge Healthtech Institute’s 3rd Annual Artificial Intelligence for Early Drug Discovery virtual event
https://t.co/Z1jwgy5Jw1
#drugdiscovery #ArtificialIntelligence

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

#cheminformatics webinar on our de novo drug design approach to using thousands of #machinelearning models for ADME/Tox properties & bioactivity, introduce some of our work to validate generative RNN approaches & discuss application beyond small molecules.
https://t.co/HoU1fItef1

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

Learn from an expert how to generate new, valid molecules that have desirable properties - such as activity against a target, low toxicity & easy synthesis - by training a neural network. Register for the free, live webinar
https://t.co/HoU1fItef1
#MachineLearning #NeuralNetworks

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

Non-animal methods for assessing toxicity are more sought after today. The U.S. ICCVAM ATWG organized an international collaboration, including @collabchem, to develop in silico models to predict acute oral toxicity. Read their findings: https://t.co/n5RyBtSduC
#toxicology #QSAR

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

Watch an intro to & demo of our enhanced & improved #machinelearning software, Assay Central. Find out what it can do for you & learn why we have so many repeat #pharmaceutical & #consumerproducts clients.
https://t.co/Qof7ubuqAT
#drugdiscovery #toxicology

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

THIS THURSDAY take a dive into the next generation of our #MachineLearning technology, Assay Central. See what we can do to advance your company's #drugdiscovery & #toxicology endeavors. Live presentation on 4/22 at 11:30 a.m. ET (8:30 a.m. PT). Register: https://t.co/S16cROCsf3

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

On May 20 @collabchem will present "Applying #MachineLearning to Build a Company Pipeline" and participate in a panel discussion of "AI Predictions for Efficacy and Safety." For more information and to register visit https://t.co/Z1jwgy5Jw1
#artificialintelligence #drugdiscovery

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

The necessity of #artificialintelligence to #pharma and #biotech R&D continues to increase. Join @collabchem as he chairs & presents at the #AI Driven Drug Repositioning & Repurposing Digital Summit on 4/20. Learn more & register to attend https://t.co/GQjGmFyvtK
#drugrepurposing

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

Discover advancements while learning how our #MachineLearning software, Assay Central, can improve your business' research and testing:
Learn more & register at https://t.co/S16cROU36B
#toxicology #drugdiscovery #deeplearning #artificialintelligence

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

Our latest publication "Discovery of 5-Nitro-6-thiocyanatopyrimidines as Inhibitors of Cryptococcus..." includes contributions from @collabchem PhD, DSc. Read about the findings on improving #antifungal therapies here https://t.co/SH6FPwcaVv
#MachineLearning

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

We're excited to announce that our new improved #drugdiscovery & #toxicology #MachineLearning software, Assay Central 2.0, is available! Learn how it can help your research efforts Thurs 4/22 at 11:30 a.m. ET (8:30 a.m. PT). Register now to save your spot
https://t.co/S16cROCsf3

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

Read Dr. Ana Cristina Puhl's interview with CBS WNCW Channel 17's Judith Retana in Raleigh, NC about our #COVID19 research and findings:
https://t.co/810D7aZXhw
#sarscov2 #ebola #drugrepurposing

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

TODAY Sr Scientist Dr. Ana Puhl presents her poster "Applying #MachineLearning To #DrugDiscovery At Collaborations Pharmaceuticals" at the North American Protein Degradation Congress' free mixer event - Women In Targeting The Undrugged.
Register at
https://t.co/PZnaxB8zYj

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

We're ready to move forward in finding therapeutics for #MPS disease-literally! Saturday our team will walk & run to support efforts of https://t.co/NKoyTm4xeV as part of the Virtual Raleigh Run for Rare MPS. Find out more about our work at https://t.co/ttKI1JhmGJ
#RareDisease

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

Our latest press release: #drugrepurposing work to find molecules that could be used to treat #COVID19 patients, in collaboration with @collabchem and NC State University biology researchers.
https://t.co/wU5wtQx6Ta

[Collaborations Pharmaceuticals, Inc. @Collabpharma]

@collabchem presents on #COVIDー19 drug repurposing on 4/20. He will discuss how to
learn from repurposing in other infectious disease areas, evaluate different #AI approaches in repurposing for Covid-19 & more.
https://t.co/GQjGmFyvtK #artificialintelligence #drugrepurposing